Normal QRS Duration Before Lithium Therapy
The normal QRS duration should be less than 120 ms in adults before initiating lithium therapy 1.
Standard QRS Duration Parameters
Based on established cardiology guidelines, normal QRS duration varies by age 1:
- Adults: <120 ms (normal); 110-119 ms (borderline/incomplete conduction delay)
- Children 8-16 years: <100 ms (normal); 90-100 ms (borderline)
- Children <8 years: <90 ms (normal); 80-90 ms (borderline)
Any QRS duration ≥120 ms in adults indicates an intraventricular conduction disturbance (complete bundle branch block or nonspecific conduction delay) 1.
Why This Matters for Lithium Therapy
Lithium can cause ECG changes that affect cardiac conduction. Establishing a baseline normal QRS duration is critical because lithium may widen the QRS complex during treatment 2, 3. In one study, 61.5% of patients showed increased QRS duration after therapeutic lithium treatment 2. Case reports document lithium-induced wide QRS complexes that can mimic acute coronary syndrome or unmask Brugada syndrome 3.
Key Baseline ECG Considerations
Before starting lithium, document:
- QRS duration (should be <120 ms)
- QTc interval (lithium can prolong this 2, 4)
- PR interval (may increase slightly with lithium 5)
- T-wave morphology (flattening/inversion is the most common lithium-induced change 5)
Clinical Pitfalls to Avoid
Do not start lithium if the baseline QRS is ≥120 ms without cardiology consultation, as pre-existing conduction disease increases risk of symptomatic bradycardia and sinus node dysfunction 6. The FDA label specifically warns about "sinus node dysfunction with severe bradycardia" and cardiac arrhythmias as adverse effects 6.
Patients with elevated systolic blood pressure (>134 mmHg) are at higher risk for lithium-induced ventricular conduction delays 2, warranting closer ECG monitoring.
While routine ECG monitoring during stable lithium therapy may not be necessary at therapeutic levels (0.6-1.2 mEq/L) 5, 4, obtaining a baseline ECG with normal QRS duration (<120 ms) is essential for comparison if cardiac symptoms develop during treatment.